Simon Farrell 4
4 · Trevi Therapeutics, Inc. · Filed Jun 21, 2023
Insider Transaction Report
Form 4
Simon Farrell
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2023-06-20$0.51/sh+6,250$3,194→ 45,650 total - Exercise/Conversion
Stock Option (right to buy)
2023-06-20−6,250→ 50,000 totalExercise: $0.51Exp: 2032-02-10→ Common Stock (6,250 underlying)
Footnotes (1)
- [F1]This option was granted on February 11, 2022. The 75,000 shares of common stock underlying the option vested as to 25% of the shares on February 11, 2023 and vest as to the remaining 75% of the shares in equal monthly installments thereafter through February 11, 2026.